📘 ❞ Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange ❝ كتاب

كتب طب بيطرى - 📖 كتاب ❞ Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange ❝ 📖

█ _ 0 حصريا كتاب ❞ Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and infected with mange ❝ 2024 mange: من كتب طب بيطرى Comparative subcutaneous administration mange J ECHEVERRI ́ A* , N MESTORINO* , & J O ERRECALDE* , *Ca ́ tedra de Farmacologı ́ a, Farmacotecnia y Terape ́ utica, Facultad Ciencias Veterinarias, Universidad Nacional La Plata, Plata, Argentina; INCAM, Vero ́ nica Experimental Station, Argentina; (Paper received: 21 March 2001; accepted for publication 19 November 2001) Correspondence (e mail: jerrecal@fcv unlp edu ar) It is well established that the efficacy any anthelmintic drug depends not only on affinity specific parasite target sites but also ability to reach high sustained drug concentrations where parasites are located Ivermectin one most useful anti parasitic agents It belongs family avermectins highly lipophilic macrocyclic lactones It a fermentation product of Streptomyces avermitilis One important characteristics iver mectin wide spectrum activity involving endo and ectoparasites effective when it applied orally, parenterally or topically Its absorption rapid by these routes of administration (Campbell, 1989, 1993) Mange an ectoparasitic disease produced mite Psoroptes ovis has major economic importance South America, especially Argentina, Chile Uruguay antici pated diseased animal there kinetic modifications largely dependent change body condition The objective of present paper was determine pharmacokinetic changes subcutaneously healthy animals animals carrying natural infections Six adult (weighing 50 ± 6 kg) five sheep naturally infested psoroptic mites showing mange lesions at least 30% their surface (weighing 43 received 200 l g kg subcutaneously, the sampling times being following post days: 0 5, 1, 2, 3, 4, 6, 8, 10, 12, 15, 18, 20, 25 30 Plasma was separated centrifugation kept frozen at ) 20 ° C until assayed Assay performed performance liquid chromatography (HPLC) recovery 85% the quantitation limit 1 ng mL Variability lower than 8% HPLC system Shimadzu LC 10 AS pump TM III 1311 model fluoromonitor column C8 reverse phase lichrospher mobile phase glacial acetic acid methanol acetonitrile (9:200:291 mL) flow rate 5 min Reagents were grade Extraction accomplished by solid–liquid method C18 cartridges eluate was evaporated, derivatizated injected into system (Alvinerie et al , 1987) Pharmacokinetic analysis wa مجاناً PDF اونلاين الطب البيطري (بالإنجليزية: Veterinary medicine) أو البيطرة هو تطبيق المبادئ الطبية والتشخيصية والعلاجية الحيوانات الإنتاجية والمنزلية والبرية يحتوي هذا القسم علي العديد الكتب المتميزة حول المجال يمارس عادة عيادة بيطرية مستشفى بيطري المزرعة للطب دور كبير حماية البشر الأمراض التي تنتقل عن طريق الأكل أصبح التخصص شائعاً السنوات الأخيرة ومن تلك التخصصات: التخدير علم السلوك الجلدية الحالات الطارئة والعناية الحثيثة الباطني امراض القلب السرطان العيون الأعصاب المشتركة المعدية التناسليات والولادة التصوير الشعاعي والجراحة

إنضم الآن وتصفح بدون إعلانات
Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange
كتاب

Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange

Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange
كتاب

Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange

حول
المتجر أماكن الشراء
مناقشات ومراجعات
QR Code
عن كتاب Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange:
Comparative pharmacokinetics of ivermectin after its subcutaneous administration in healthy sheep and sheep infected with mange من كتب طب بيطرى

Comparative pharmacokinetics of ivermectin after its subcutaneous
administration in healthy sheep and sheep infected with mange
J. ECHEVERRI
́
A*
,
N. MESTORINO*
,
&
J. O. ERRECALDE*
,
Ca
́
tedra de Farmacologı
́
a, Farmacotecnia y Terape
́
utica, Facultad de Ciencias Veterinarias, Universidad Nacional de La Plata, La Plata,
Argentina;
INCAM, Vero
́
nica Experimental Station, La Plata, Argentina;
(Paper received: 21 March 2001; accepted for publication 19 November 2001)
Correspondence (e-mail: jerrecal@fcv.unlp.edu.ar)
It is well established that the efficacy of any anthelmintic drug
depends not only on its affinity for specific parasite target sites
but also on its ability to reach high and sustained drug
concentrations where the parasites are located.
Ivermectin is one of the most useful anti-parasitic agents. It
belongs to the family of avermectins that are highly lipophilic
macrocyclic lactones. It is a fermentation product of
Streptomyces
avermitilis
. One of the most important characteristics of iver-
mectin is its wide spectrum of activity involving endo- and
ectoparasites.
Ivermectin is effective when it is applied orally, parenterally or
topically. Its absorption is rapid by any of these routes of
administration (Campbell, 1989, 1993).
Mange is an ectoparasitic disease produced by the mite
Psoroptes ovis
. It has major economic importance in South
America, especially Argentina, Chile and Uruguay. It is antici-
pated that in the diseased animal there are kinetic modifications
largely dependent on the change of body condition. The objective
of the present paper was to determine the pharmacokinetic
changes of ivermectin when applied subcutaneously to healthy
animals and animals carrying natural mange infections.
Six adult and healthy sheep (weighing 50 ± 6 kg) and five
sheep naturally infested with psoroptic mites and showing
mange lesions on at least 30% of their body surface (weighing
43 ± 6 kg) received 200
l
g/kg ivermectin subcutaneously, the
sampling times being at the following post-administration days:
0.5, 1, 2, 3, 4, 6, 8, 10, 12, 15, 18, 20, 25 and 30. Plasma was
separated by centrifugation and kept frozen at
)
20
°
C until
assayed. Assay was performed by high-performance liquid
chromatography (HPLC). The recovery was 85% and the
quantitation limit was 0.1 ng/mL. Variability was lower than
8%. The HPLC system was a Shimadzu LC-10 AS pump and TM
III 1311 model fluoromonitor. The column was a C8 reverse
phase lichrospher and the mobile phase was glacial acetic acid/
methanol/acetonitrile (9:200:291 mL) at a flow rate of 1.5 mL/
min. Reagents were HPLC grade. Extraction was accomplished
by the solid–liquid method with C18 cartridges. The eluate was
evaporated, derivatizated and injected into the HPLC system
(Alvinerie
et al
., 1987). Pharmacokinetic analysis wa
الترتيب:

#2K

0 مشاهدة هذا اليوم

#49K

15 مشاهدة هذا الشهر

#24K

10K إجمالي المشاهدات
عدد الصفحات: 2.